Lipoproteins, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham offspring study

Metabolism: Clinical and Experimental

Volumn 45, Issue 10, 1996, Pages 1267-1272

  Siegel, Richard D ^a   Cupples, Adrienne ^b   Schaefer, Ernst J ^b   Wilson, Peter W F ^b  

^a TUFTS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY RISK; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PARTICLE SIZE; PRIORITY JOURNAL; RISK ASSESSMENT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0029840813     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90246-2     Document Type: Article

References (38)

1. Garcia MJ, McNamara PM, Kannel WB: Morbidity and mortality in diabetics in the Framingham population. Diabetes 23:105-111, 1974
2. The Expert Panel: Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. JAMA 269:3015-3023, 1993
3. Garg A: Management of dyslipidemia in IDDM patients. Diabetes Care 17:224-234, 1994
4. Feinleib M, Kannel WB, Garrison RJ, et al: The Framingham Offspring Study: Design and preliminary data. Prev Med 4:518-525, 1975
5. McNamara JR, Schaefer EJ: Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clin Chim Acta 166:1-8, 1987
6. 2+ precipitation procedure for quantitation of high-density lipoprotein cholesterol. Clin Chem 28:1379-1388, 1982
7. Lipid Research Clinics: The Lipid Research Clinics Population Studies Data Book, vol 2: The Prevalence Study - Nutrient Intake. NIH Publication No. 82-2014. Bethesda, MD, National Institutes of Health, 1982
8. Schaefer EJ, Lamon-Fava S, Odovas JM, et al: Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-1 levels in the Framingham Offspring Study. J Lipid Res 35:871-882, 1994
9. Schaefer EJ, Lamon-Fava S, Cohn SD, et al: Effects of age, gender and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study. J Lipid Res 35:779-792, 1994
10. Silberman SR, Armentrout MA, Vella FA, et al: Macra™ Lp(a) for quantitation of human lipoprotein(a) by enzyme-linked immunoassay. Clin Chem 36:961, 1990 (abstr)
11. Jenner JL, Ordovas JM, Lamon-Fava S, et al: Effects of age, gender and menopausal status on plasma lipoprotein(a) levels: The Framingham Offspring Study. Circulation 87:1135-1141, 1993
12. Belcher JD, Egan JO, Bridgman G, et al: A microenzymatic method to measure cholesterol and triglyceride in lipoprotein subfractions separated by density gradient ultraultracentrifugation from 200 microliters of plasma or serum. J Lipid Res 32:359-370, 1991
13. Ordovas JM, Litwack-Klein L, Wilson PWF, et al: Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apo E1 and apo E5 isoforms. J Lipid Res 28:371-380, 1987
14. Swinkels DW, Demacker PHM, Hendricks JCM, et al: Low density lipoprotein subfractions and relationship of other risk factors for coronary artery disease in healthy individuals. Arteriosclerosis 9:604-613, 1989
15. Krauss RM, Burke DJ: Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 23:97-104, 1982
16. Betteridge DJ: Diabetic dyslipidemia. Am J Med 96:25S-31S, 1994 (suppl 6A)
17. Dunn FL: Plasma lipid and lipoprotein disorders in IDDM. Diabetes 41:102-106, 1992 (suppl 2)
18. Garber AJ, Vinik AI, Crespin SR: Detection and management of lipid disorders in diabetic patients. Diabetes Care 15:1068-1074, 1992
19. Howard BV: Lipoprotein metabolism in diabetes. Curr Opin Lipidol 5:216-220, 1994
20. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
21. Briones ER, Mao SJT, Palumbo PJ, et al: Analysis of plasma lipids and apolipoproteins in insulin-dependent and non-insulin-dependent diabetics. Metabolism 33:42-49, 1984
22. Kannel WB: Lipids, diabetes and coronary heart disease: Insights from the Framingham Study. Am Heart J 110:1100-1106, 1985
23. Walden CE, Knopp RH, Wahl PW, et al: Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations. N Engl J Med 311:953-959, 1984
24. Taskinen M-R: Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus. Diabetes 41:12-17, 1992 (suppl 2)
25. Haffner SM: Lipoprotein(a) and diabetes: An update. Diabetes Care 16:835-840, 1993
26. Haffner SM, Tuttle KR, Rainwater DL: Decrease of lipoprotein(a) with improved glycemic control in IDDM subjects. Diabetes Care 14:302-307, 1991
27. Jenkins AJ, Steele JS, Janus ED, et al: Increased plasma apolipoprotein(a) levels in IDDM patients with microalbuminuria. Diabetes 40:787-790, 1991
28. Haffner SM, Morales PA, Stern MP, et al: Lp(a) concentrations in NIDDM. Diabetes 41:1267-1272, 1992
29. Kikuchi T, Onuma T, Shimura M, et al: Different changes in lipoprotein(a) levels from lipid levels of other lipoproteins with improved glycemic control in patients with NIDDM. Diabetes Care 17:1059-1061, 1994
30. Rainwater DL, MacLure JW, Stern MP, et al: Effects of NIDDM on Lp(a) concentration and apolipoprotein(a) size. Diabetes 43:942-946, 1994
31. Campos H, Genest JJ, Blijlevens E, et al: Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb 12:187-195, 1992
32. James RW, Pometta D: The distribution profiles of very low-density and low-density lipoproteins in poorly controlled male type 2 (non-insulin dependent) diabetic patients. Diabetologia 34:246-252, 1991
33. Feingold KR, Grunfeld C, Pang M, et al: LDL subclass phenotypes and triglyceride metabolism in NIDDM. Arterioscler Thromb 12:1496-1502, 1992
34. Reaven GM, Chen Y-DI, Jeppesen J, et al: Insulin resistance and hyperinsulinemia in individuals with small dense low-density lipoprotein particles. J Clin Invest 92:141-146, 1993
35. Eto M, Watanabe K, Iwahima Y, et al: Apolipoprotein E polymorphism and hyperlipemia in type II diabetics. Diabetes 35:374-382, 1986
36. Campos H, Wilson PWF, Jimenez D, et al: Differences in apolipoproteins and low-density lipoprotein subfractions in post-menopausal women on and off estrogen therapy: Results from the Framingham Offspring Study. Metabolism 39:1033-1038, 1990
37. Campos H, McNamara JR, Wilson PWF, et al: Differences in low density lipoprotein subfractions and apolipoproteins in premenopausal and postmenopausal women. J Clin Endocrinol Metab 67:30-35, 1988
38. Haffner SM, Mykkanen L, Stern MP, et al: Greater effect of diabetes on LDL size in women than men. Diabetes Care 17:1164-1171, 1994